KOL Perspectives: Belimumab for Lupus
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
› The briefing includes analysis of KOL opinion on the following topic areas:
– Types of lupus patients suitable for subQ BEL
– Anticipated switching of patients currently on IV BEL to subQ BEL in the first year of its launch
– Starting BEL-naïve patients on subQ vs. IV BEL
– Opinion on potential need for patients to administer the first couple of subQ BEL doses of in-office
– Understanding of ‘inadequate response’ to therapy, and ‘uncontrolled’ lupus patients
Scope
› The insight briefing is based on Sociable Pharma’s analysis of primary research with our lupus key opinion leaders (KOLs)
› In total, we conducted interviews with 14 KOLs:
– Seven Europe-based & seven US-based
– Interviews performed during July & August, 2017
> KOL data is analyzed to produce:
– Charts summarizing KOL opinions
– Chart call-outs of key information & details
– KOL quotes
– Summary of KOL reporting trends
– Insight from Sociable Pharma's analysts
Key Highlights
Most KOLs had a positive view of the BLISSBELIEVE study, and consider a moderate patient population to be appropriate for the trial
Most KOLs highlighted that the primary endpoint assessed in the BLISS-BELIEVE study is stringent & rigorous, and is better than SRI
Lack of consensus among KOLs in terms of anticipated future use of the BEL + RTX combination therapy in clinical practice
Reasons to Buy
Combines Qualitative & semi-quantitative insight from key opinion leaders on " Belimumab for Lupus "
Includes insight & recommendations from our disease-specific healthcare analysts
Utilizes independent expert viewpoints to validate the impact of new clinical data & emerging trends on management of Lupus
Provides cost-effective support for your advisory boards, with topics acting as a catalyst for further expert discussion
Table of Contents
Frequently asked questions
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.